Cardiovascular Diagnostic Testing Market Expected to Reach $15.4 Billion by 2030

Cardiovascular diagnostic market was valued at $6,876.29 million in 2020, and is projected to reach $15,430.46 million by 2030, registering a CAGR of 8.3% from 2021 to 2030. Cardiovascular diseases are a leading cause of mortality in humans, and millions of individuals worldwide die from acute cardiovascular events every year. Several Laboratory developed tests as well as in-vitro diagnostic tests are used for diagnostic and prognostic purposes.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Becton, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Abbott Laboratories, Dickinson and Company, bioMérieux, Inc., PerkinElmer, Inc., Siemens AG, F. Hoffmann-La Roche Ltd, Tosoh Corporation, Danaher Corporation

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/14656

By type the market is fragmented into laboratory developed test and In-vitro diagnostic test. Laboratory developed test is further categorized into lipoprotein test, angiotensin test, fibrinogen test, serum uric acid test, and High-sensitivity C-reactive protein (hsCRP). In-vitro diagnostic test is further categorized into electrocardiogram test, echocardiography test, transesophageal echocardiogram test, and others. The In-vitro diagnostic test segment led the market in 2020, and is expected to retain its dominance during the forecast period.

By panel the market includes Atherosclerotic cardiovascular disease (ASCVD) risk panel with score.

By end user the market is categorized into laboratory testing facilities, academic institutes, and point-of-care testing facilities. The laboratory testing facilities exhibited the highest growth in 2020, and is expected to continue this trend during the forecast period, owing to rise in cardiovascular diseases.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/14656

𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘

By type, the in- vitro diagnostic test segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.

By end user, the laboratory testing facilities segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.

By region, North America is expected to experience market growth at the highest rate, registering a CAGR of 8.3% during the forecast period.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:

Artificial Intelligence in Medicine Market -- https://www.alliedmarketresearch.com/artificial-intelligence-in-medicine-market

Optical Imaging Market -- https://www.alliedmarketresearch.com/optical-imaging-market

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.